A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis
- 31 May 2009
- journal article
- research article
- Published by Elsevier BV in Phytomedicine
- Vol. 16 (5), 391-400
- https://doi.org/10.1016/j.phymed.2009.02.002
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Liver disease in Egypt: Hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factorsHepatology, 2006
- Active Surveillance for Acute Viral Hepatitis in Rural Villages in the Nile DeltaClinical Infectious Diseases, 2006
- Global epidemiology of hepatitis C virus infectionThe Lancet Infectious Diseases, 2005
- Two-year results of a randomised double-blinded trial evaluating silymarin for chronic hepatitis CDigestive and Liver Disease, 2005
- Acute viral hepatitis in Hanoi, Viet NamTransactions of the Royal Society of Tropical Medicine and Hygiene, 1996
- Antioxidant activity of silybin in vivo during long-term iron overload in ratsGastroenterology, 1995
- Analysis of Semiparametric Regression Models for Repeated Outcomes in the Presence of Missing DataJournal of the American Statistical Association, 1995
- Protection by silibinin against Amanita phalloides intoxication in beaglesToxicology and Applied Pharmacology, 1984
- Chemotherapy of Amanita phalloides Poisoning with Intravenous SilibininHuman Toxicology, 1983
- THE TREATMENT OF ACUTE INFECTIOUS HEPATITIS. CONTROLLED STUDIES OF THE EFFECTS OF DIET, REST, AND PHYSICAL RECONDITIONING ON THE ACUTE COURSE OF THE DISEASE AND ON THE INCIDENCE OF RELAPSES AND RESIDUAL ABNORMALITIES 1JCI Insight, 1955